Atezolizumab for PD-L1-Selected Patients with NSCLC. Reply

N Engl J Med. 2021 Feb 11;384(6):584-585. doi: 10.1056/NEJMc2032432.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Lung Neoplasms* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • atezolizumab